These data suggest that CXCR2 inhibition does indeed protect the pancreas from chronic pancreatic inflammation, first through inhibition of neutrophil chemotaxis and second through neutrophil‐independent processes, potentially disruption of the coordination of the innate immune response, and interference with monocyte chemotaxis. This evidence concerns the gene CXCR2 and inflammatory response.